Clinical Research Directory
Browse clinical research sites, groups, and studies.
Safety and Efficacy of Corneal Cross-linking in Subjects With Keratoconus
Sponsor: Glaukos Corporation
Summary
Clinical Trial to Evaluate the Safety and Efficacy of Corneal Cross-linking in Subjects with Keratoconus.
Official title: A Dose Ranging, Multicenter, Sham-Controlled Study to Evaluate the Safety and Efficacy of Corneal Cross-linking in Subjects With Keratoconus
Key Details
Gender
All
Age Range
18 Years - 55 Years
Study Type
INTERVENTIONAL
Enrollment
150
Start Date
2022-03-08
Completion Date
2026-02
Last Updated
2024-07-08
Healthy Volunteers
No
Conditions
Interventions
NXL Energy 1
Riboflavin drops + NXL System to Total Energy Level 1
NXL Energy 2
Riboflavin drops + NXL System to Total Energy Level 2
NXL Energy 3
Riboflavin drops + NXL System to Total Energy Level 3
Sham Treatment
Sham Drops and No exposure to NXL system
Locations (3)
Glaukos Investigative Site
Dothan, Alabama, United States
Glaukos Investigative Site
Teaneck, New Jersey, United States
Glaukos Investigative Site
Westerville, Ohio, United States